biotech investment

Market Access

Political uncertainties, tariffs, funding crunch? LSX World ...

The weather was hot in London for this year’s LSX World Congress – but what was the atmosphere like at Europe’s leading partnering, strategy, and investment event?

Market Access

Seeing is investing: The power of visuals at every stage of ...

Whether your biotech start-up is in its infancy or on the verge of a major acquisition, how you communicate your work – through clear messaging and impactful visuals – can play a pivotal ro

R&D

LSX USA Jonah Comstock and Eloise McLennan Wrapup

Investment outlook: Key takeaways from LSX USA

Investment and strategic partnerships are the lifeblood of innovation in healthcare, driving groundbreaking discoveries and accelerating the development of life-changing therapies.

R&D

Brighter times ahead for biotech in 2024?

The biotech industry experienced heady highs in early 2021, but has since suffered from a tight financial climate that has brought bankruptcies and widespread redundancies.

R&D

Investing in the gleams of positivity and hope for life scie...

In this third instalment of the five-part, festive series of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Mark Andrews, investment director of life sciences funds at Brit

Digital

An investor’s perspective on bio and tech

Increasingly, the life sciences world is characterised by the collision of the worlds of technology and biology.